Staley Brod, MD
Enriched profileProfessor of Neurology, Director, Division of MS/Neuro-immunology (per 2019 MCW listing; not confirmed as current) · Medical College of Wisconsin
Staley Brod is Professor of Neurology, Director, Division of MS/Neuro-immunology (per 2019 MCW listing; not confirmed as current) at Medical College of Wisconsin. OpenAlex indexes 98 publications with 1,863 citations (h-index 25); ClinicalTrials.gov lists 3 registered studies with this person as an investigator.
Data verified 23 Oct 2026
Overview
Updated 24 Oct 2026
Staley Brod, M.D., is Professor of Neurology, Director, Division of MS/Neuro-immunology (per 2019 MCW listing at Medical College of Wisconsin. The public record shows 98 publications with 1,863 citations (h-index 25), centered on Multiple Sclerosis Research Studies, T-cell and B-cell Immunology, Psoriasis: Treatment and Pathogenesis. It also documents an investigator role on 3 registered clinical trials, industry payments reported by 13 companies.
- Top research focus: Multiple Sclerosis Research Studies
- 3 registered trials on ClinicalTrials.gov
- Open Payments reporting from 13 companies
Generated from the cited public record · current as of 24 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 3 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 46.
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 24 Oct 2026
Listed as an investigator on 3 registered studies on ClinicalTrials.gov. The most recent:
- Pilot Clinical Trial of ACTHar Gel 14 Days Subcutaneous (SQ)Versus ACTHar Gel Five Days SQ for the Treatment of MS Exacerbations
Sponsor: The University of Texas Health Science Center, Houston
- AT RISK FOR MS - Clinical Conversion of Female Monozygotic Twins Discordant for CIS/MS
Sponsor: The University of Texas Health Science Center, Houston
- Interferon-Alpha for Diabetes Mellitus Type 1
Sponsor: The University of Texas Health Science Center, Houston
Industry payments
Updated 24 Oct 2026
13 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- ANI Pharmaceuticals, Inc.Program year202526 payments$32,801openpaymentsdata.cms.gov ↗
- EMD Serono, Inc.Program year202521 payments$25,250openpaymentsdata.cms.gov ↗
- Boston Scientific CorporationProgram year20251 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Musculoskeletal
100%gamma-Aminobutyric Acid-ergic Agonist100%Baclofen100%Part D≥12 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Anti-Inflammatory Agents: An Approach to Prevent Cognitive Decline in Alzheimer’s Disease
Journal of Alzheimer s Disease
2021 - Review of approved NMO therapies based on mechanism of action, efficacy and long-term effects
Multiple Sclerosis and Related Disorders
2020 - Tumefactive demyelination: Clinical outcomes, lesion evolution and treatments
Multiple Sclerosis Journal - Experimental Translational and Clinical
2019 - Ingested ACTH blocks Th17 production by inhibiting GALT IL-6
Journal of the Neurological Sciences
2019
Most-cited works
by citation count (OpenAlex)- 01
- 02
- 03Unregulated inflammation shortens human functional longevityArticle91 citations2000
- 04
- 05Restricted T cell expression of IL-2/IFN-gamma mRNA in human inflammatory diseaseArticle73 citations1991
Network
Updated 24 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 24 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Mentions by others
where others cite or feature them- Other
care.healthline.com/find-care/provider/dr-staley-brod-1740217322
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →care.healthline.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 24 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ocpe.mcw.edu ↗
- Graduate
University of Toledo College of Medicine and Life Sciences
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →care.healthline.com ↗
Editorial & leadership roles
journal and society appointments- Director
Division of MS/Neuro-immunology, Medical College of Wisconsin
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ocpe.mcw.edu ↗
Secondary affiliations
appointments beyond the home institution- Froedtert Hospital
Milwaukee
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →care.healthline.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Brett Kissela, MD
Medical College of Wisconsin
Razelle Kurzrock, MD
Medical College of Wisconsin
Mary Horowitz, MD
Medical College of Wisconsin
Reza Shaker, MD
Medical College of Wisconsin
Bruce Miller, MD
University of California, San Francisco (UCSF)
Brett Kissela, MD
Medical College of Wisconsin
Bradley Boeve, MD
Mayo Clinic
Richard Lipton, MD
Albert Einstein College of Medicine